Patent ID: 8716294

Claim:
A method of treating delayed-type hypersensitivity, contact dermatitis, atopic dermatitis, or septic shock in a mammal comprising administering to the mammal in need thereof a therapeutically effective amount of a compound of formula I wherein: X is 2-thienyl, 3-thienyl, 2-furyl, 3-furyl, or phenyl, each unsubstituted, mono-substituted, di-substituted, or tri-substituted with, independently, OH, halogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, or (C 1 -C 4 ) alkoxy-(C 1 -C 4 ) alkyl; R 1 and R 4 are, independently, H or C 1 -C 4 alkyl; R 2a and R 2b are, independently, H, OH, or C 1 -C 4 alkyl, or, together, R 2a and R 2b are C═O; R 3a and R 3b are, independently, H, OH, or C 1 -C 4 alkyl, or, together, R 3a and R 3b are C═O; and R X is H, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, or (C 1 -C 4 ) alkoxy-(C 1 -C 4 ) alkyl; or a pharmaceutically acceptable salt thereof, wherein the compound of formula I is administered in the absence of another therapeutic agent.